Reviews
Description
Gynaecological cancers are categorised as 'rare' diseases, although collectively they affect over 16,000 women each year in the UK alone. There is a lack of real understanding of these conditions compared with other malignancies, possibly owing to their relative rarity when viewed as individual diseases. The 60th RCOG Study Group brought together a range of experts to examine as many biological aspects of gynaecological cancers as possible, including both surgical and non-surgical therapies. This book presents the findings of the Study Group, with contents including: - current understanding of the biology of gynaecological cancers - translation of biology to the clinic - state of the art in imaging and therapy - current clinical trials - advances in multimodal therapy - individualised treatment.
EXTRA 10 % discount with code: EXTRA
The promotion ends in 21d.06:57:54
The discount code is valid when purchasing from 10 €. Discounts do not stack.
Gynaecological cancers are categorised as 'rare' diseases, although collectively they affect over 16,000 women each year in the UK alone. There is a lack of real understanding of these conditions compared with other malignancies, possibly owing to their relative rarity when viewed as individual diseases. The 60th RCOG Study Group brought together a range of experts to examine as many biological aspects of gynaecological cancers as possible, including both surgical and non-surgical therapies. This book presents the findings of the Study Group, with contents including: - current understanding of the biology of gynaecological cancers - translation of biology to the clinic - state of the art in imaging and therapy - current clinical trials - advances in multimodal therapy - individualised treatment.
Reviews